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Abstract
We evaluated the roles of bone morphogenetic protein (BMP)-6, BMP-4 and parathyroid hormone-related protein
(PTHrP) in the hypertrophic conversion using mouse chondrogenic EC cells, ATDC5. In ATDC5 cells, the expression of
BMP-6 and PTHrP receptor mRNAs increased in parallel with the progression of chondrogenic differentiation of these cells,
exhibiting a time course similar to that of type II collagen, a phenotypic marker of proliferating chondrocytes, while BMP-4
mRNA was continuously expressed throughout the differentiation processes. The expression of type X collagen mRNA, a
phenotypic marker of hypertrophic chondrocytes, was upregulated by BMP-6 and BMP-4, and downregulated by PTHrP(1^
141). The expression of BMP-6 mRNA was upregulated while that of BMP-4 mRNA was downregulated by both BMP-6
and BMP-4. Moreover, the expression of BMP-6 mRNA was downregulated by PTHrP(1^141). Furthermore, even in the
presence of PTHrP(1^141), BMP-6 increased the transcript level of type X collagen in a dose-dependent manner. These
results indicate that transiently expressed BMP-6 promotes the hypertrophic conversion in association with the augmentation
of BMP-6 gene expression by BMP signals and that both BMP-6 and PTHrP coordinately regulate the rate of the
hypertrophic conversion of ATDC5 cells. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Chondrogenic di¡erentiation, a key event during
endochondral bone formation, consists of a series
of events in which di¡erentiated chondrocytes prolif-
erate, mature and become hypertrophied. This se-
quential cellular event is under the regulatory control
by a variety of growth/di¡erentiation molecules, in-
cluding bone morphogenetic proteins (BMPs) and
parathyroid hormone-related protein (PTHrP) se-
creted from either chondrocytes or perichondrium
in an autocrine/paracrine fashion [1^5]. Elucidating
the molecular mechanisms that underlie the hyper-
trophic conversion of proliferating chondrocytes
and uncovering the actions of these molecules during
this distinct process is the current challenge.
Accumulating evidence shows that BMPs are po-
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tent stimulators of chondrogenic di¡erentiation;
BMP-4 upregulates the levels of type II collagen
and aggrecan mRNAs in cultured articular chondro-
cytes [6] ; and OP-1/BMP-7 promotes growth and
maturation in chick sternal chondrocytes [3]. Among
BMPs, BMP-6 is characteristically expressed in pre-
hypertrophic chondrocytes [7,8], and induces chon-
drogenesis when ectopically expressed in nude mice
transplanted with CHO cells overexpressing BMP-6
[7]. Although it is suggested that upregulation of the
BMP-6 gene precedes hypertrophy of chondrocytes
in vitro [1], little remains known regarding the e¡ects
of BMP-6 expressed in chondrocytes as well as the
regulation of its gene expression.
PTHrP mRNA is expressed in perichondrium of
long bones and proliferating chondrocytes [5], while
PTHrP protein is expressed mostly at the interface of
proliferating and hypertrophic chondrocytes, colocal-
izing with PTH/PTHrP receptor (-R) mRNA [4,5].
The observation that homozygous mice carrying ei-
ther PTHrP or PTH/PTHrP-R null mutation each
exhibit widespread abnormalities of cartilage devel-
opment indicates that PTHrP restrains the rate of
chondrogenic di¡erentiation [8^11]. These observa-
tions collectively indicate that chondrogenic di¡eren-
tiation is under negative control by PTHrP/PTHrP-R
signal.
We and others previously demonstrated that clo-
nal mouse embryonal carcinoma (EC) cells, ATDC5,
reproduce the multistep chondrogenic di¡erentiation
processes in vitro. Undi¡erentiated ATDC5 cells dif-
ferentiate into chondrocytes through a cellular con-
densation stage, and di¡erentiated ATDC5 cells then
go through the sequential processes of proliferation,
maturation, hypertrophic conversion and calci¢ca-
tion [12^16]. Taking advantage of the sequential dif-
ferentiation in ATDC5 cells occurring in a synchro-
nous manner, we studied the e¡ects of BMP-6, BMP-
4 and PTHrP on the hypertrophic conversion in
these cells.
2. Materials and methods
2.1. Materials
Human recombinant BMP-6 was a generous gift
from Dr. J.M. Wozney (Genetics Institute, Cam-
bridge, MA). Xenopus recombinant BMP-4 was a
generous gift from Takeda Chemical Industries (Osa-
ka, Japan) [17]. Human recombinant PTHrP(1^141),
a full-length form of this molecule, was kindly do-
nated by Dr. T.J. Martin (St. Vincent’s Institute of
Medical Research, Victoria, Australia).
2.2. Cells and culture conditions
ATDC5 cells were cultured as previously described
[13^15]. Brie£y, cells were maintained in a log growth
phase in DMEM/Ham’s F12 hybrid medium (Flow
laboratories, Irvine, UK) containing 5% (v/v) FBS
(Gibco BRL, Gaithersburg, MD), 10 Wg/ml human
transferrin (Boehringer Mannheim, Mannheim, Ger-
many), and 3U1038 M sodium selenite (Sigma
Chemical Co., St. Louis, MO) (the maintenance me-
dium) at 37‡C in a humidi¢ed 5% CO2/95% air at-
mosphere and were passaged every 3 days. Chondro-
genesis and cartilage nodule formation could be
induced only in a postcon£uent phase when cells
were cultured in the maintenance medium supple-
mented further with 10 Wg/ml bovine insulin (Wako
Pure Chemical, Osaka, Japan) (the di¡erentiation
medium). Cells were cultured in the di¡erentiation
medium for 21 days until the growth of cartilage
nodules ceased. Induction of calci¢cation was
achieved when medium was replaced with K-MEM
(Flow Laboratories) containing 5% (v/v) FBS, 10 Wg/
ml human transferrin, 3U1038 M sodium selenite
and 10 Wg/ml bovine insulin (the calci¢cation me-
dium) and culture was continued at 37‡C in a hu-
midi¢ed 3% CO2/97% air atmosphere. In the present
study, we plated ATDC5 cells in a log growth phase
in 6-multiwell plastic plates at an initial cell density
of 6U104 cells/well and cultured these cells for a
total of 42 days with medium replacement every oth-
er day. Cells were cultured for the initial 21-day pe-
riod in the di¡erentiation medium in a 5% CO2/95%
air atmosphere and then for the subsequent 21-day
period in the calci¢cation medium in a 3% CO2/97%
air atmosphere. For the examination of the e¡ects of
BMP-6, BMP-4 and PTHrP in di¡erentiated ATDC5
cells, cells were cultured for the initial 21-day period
in the di¡erentiation medium in a 5% CO2/95% air
atmosphere and then cells were treated for the indi-
cated time periods with various doses of the test
substances in the absence of insulin.
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2.3. RNA extraction and Northern analysis
Total RNA was prepared from the cultures as pre-
viously described [13^16]. For Northern hybridiza-
tion, total RNA (20 Wg) was denatured, separated
by 1% agarose gel electrophoresis, and transferred
onto Nytran membranes (Schleicher and Schuell,
Dassel, Germany). Hybridization probes were pre-
pared by the random-primer method with a BcaB-
EST labeling kit (Takara, Shiga, Japan). The follow-
ing cDNA fragments were used as hybridization
probes: a 0.42-kb fragment of BMP-6 mRNA; a
0.6-kb fragment of BMP-4 mRNA; a 0.42-kb frag-
ment of PTH/PTHrP receptor mRNA; a 1.4-kb
EcoRI fragment of pKT1180 for K1(II) collagen
mRNA [18]; and a 0.65-kb HindIII fragment of
pSAm10h for K1(X) collagen mRNA [19]. After hy-
bridization, the membranes were exposed to X-Omat
¢lms (Kodak, Rochester, NY) at 380‡C with Cronex
lightening plus intensifying screens (DuPont, Boston,
MA).
3. Results
3.1. Expression patterns of BMP-6,BMP-4 and PTH/
PTHrP-R mRNAs during the processes of
chondrogenic di¡erentiation of ATDC5 cells
We previously showed that chondrogenic di¡eren-
tiation of ATDC5 cells took place in the presence of
insulin and that transitions of the di¡erentiation
stages occurred in a synchronous manner as evi-
denced by the orderly expression of cartilage pheno-
typic marker genes [13]. In the presence of insulin,
ATDC5 cells reached con£uence 5 days after plating,
and initiated chondrogenesis. The process proceeded
orderly in a synchronous manner as evidenced by the
expression of phenotypic marker genes with cartilage
characteristics, as previously reported [13]. Cellular
condensation occurred on day 7, and the formation
and growth of cartilaginous nodules were observed
from day 9 to day 21 followed by a calci¢cation
process which began on day 35. We extracted total
RNA at the time points indicated, and analyzed the
transcript levels of BMP-6, BMP-4 and PTH/PTHrP-
R genes as well as those of type II collagen and type
X collagen genes, phenotypic markers of proliferat-
ing and hypertrophic chondrocytes, respectively (Fig.
1). The expression of BMP-6 and PTH/PTHrP-R
mRNAs were ¢rst observed on day 7, increased in
parallel with the progression of chondrogenic di¡er-
entiation of ATDC5 cells, exhibiting a time course
similar to that of the type II collagen mRNA expres-
sion, and then declined until the cells became calci-
¢ed. BMP-4 mRNA was expressed at the undi¡eren-
tiated stage and its level declined as the cartilage
nodules stopped growing after 2 weeks in culture,
but was maintained constitutively. BMP-2 was not
expressed throughout chondrogenic di¡erentiation
processes in ATDC5 cells (data not shown).
3.2. E¡ects of exogenously administered BMP-6 and
BMP-4 on the expression of type X collagen
mRNA in di¡erentiated ATDC5 cells
Previous studies showed that BMP-6 and BMP-4
Fig. 1. Expression patterns of BMP-6, BMP-4 and PTH/PTH-R
mRNAs during the processes of chondrogenic di¡erentiation in
ATDC5 cells. Undi¡erentiated ATDC5 cells were plated as de-
scribed in Section 2 and cultured for 42 days. Total RNA was
prepared from ATDC5 cells on days 3, 5, 7, 9, 12, 14, 18, 21,
35 and 42, and subjected to Northern analysis (20 Wg of total
RNA per lane). The transcript levels of type II collagen and
type X collagen were also examined. The same ¢lter was
hybridized with these 32P-labeled probes. The integrity of the
RNA analyzed was con¢rmed by ethidium bromide staining, as
shown in the bottom panel. Three independent experiments
were performed and gave similar results.
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were expressed in di¡erentiated chondrocytes or peri-
chondrium [1,7,20,21]. However, the e¡ects of BMP-
6 and BMP-4 on the hypertrophic conversion of
chondrocytes remain to be elucidated. We assessed
Fig. 2. E¡ect of exogenously administered BMP-6 on the expression of BMP-6, BMP-4 and type X collagen mRNA in di¡erentiated
ATDC5 cells. Cells were cultured in 6-multiwell plastic plates as described in Section 2 for 21 days in the di¡erentiation medium and
were then exposed for the indicated time periods to 1000 ng/ml of BMP-6 (time-dependence), and an additional 48 h to either vehicle
or BMP-6 (20, 50, 250 and 1000 ng/ml) (dose-dependence). Total RNA were prepared and subjected to Northern analysis (20 Wg of
total RNA per lane). The same ¢lter was hybridized with these 32P-labeled probes. The integrity of the RNA analyzed was con¢rmed
by ethidium bromide staining, as shown in the bottom panel. Three independent experiments were performed and gave similar results.
Fig. 3. E¡ect of exogenously administered BMP-4 on the expression of BMP-6, BMP-4 and type X collagen mRNA in di¡erentiated
ATDC5 cells. Cells were cultured in 6-multiwell plastic plates as described in Section 2 for 21 days in the di¡erentiation medium and
were then exposed for the indicated time periods to 1000 ng/ml of BMP-4 (time-dependence), and for an additional 48 h to either ve-
hicle or BMP-4 (20, 50, 250 and 1000 ng/ml) (dose-dependence). Total RNA were prepared and subjected to Northern analysis (20 Wg
of total RNA per lane). The same ¢lter was hybridized with these 32P-labeled probes. The integrity of the RNA analyzed was con-
¢rmed by ethidium bromide staining, as shown in the bottom panel. Three independent experiments were performed and gave similar
results.
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by Northern analysis the e¡ects of BMP-6 and BMP-
4 on the expression of type X collagen mRNA in
di¡erentiated ATDC5 cells. As shown in Figs. 2
and 3, both BMP-6 and BMP-4 upregulated the ex-
pression of type X collagen mRNA in time- and
dose-dependent manners. These observations suggest
that they are potent stimulators of the hypertrophic
conversion of ATDC5 cells.
3.3. Regulation of the expression of BMP-6 and
BMP-4 mRNAs by BMP signals in di¡erentiated
ATDC5 cells
BMP signals mediated by BMP-6 and BMP-4
stimulate the hypertrophic conversion of ATDC5
cells. Next, we examined the regulation of the ampli-
tude of BMP signals by BMP-6 (Fig. 2) and BMP-4
(Fig. 3). Exogenously administered BMP-6 and
BMP-4 upregulated the transcript level of BMP-6
gene in time- and dose-dependent manners and
downregulated that of BMP-4. These results indicate
that the amplitude of endogenous BMP-4 signal was
maintained relatively constant by the negative-feed-
back mechanisms by BMP signals and that BMP-6
gene expression was augmented by BMP signals in
di¡erentiated ATDC5 cells.
3.4. E¡ects of exogenously administered
PTHrP(1^141) on the expression of type X
collagen and BMP-6 mRNAs in di¡erentiated
ATDC5 cells
PTHrP is inhibitory to chondrogenic di¡erentia-
Fig. 4. E¡ect of exogenously administered PTHrP(1^141) on the expression of BMP-6 and type X collagen mRNAs in di¡erentiated
ATDC5 cells. Cells were cultured in 6-multiwell plastic plates as described in Section 2 for 21 days in the di¡erentiation medium and
were then exposed for the indicated time periods to 1038 M of PTHrP(1^141) (time-dependence), and for an additional 48 h to either
vehicle or PTHrP(1^141) (10311, 10310, 1039, 1038 and 1037 M) (dose-dependence). Total RNA were prepared and subjected to
Northern analysis (20 Wg of total RNA per lane). The same ¢lter was hybridized with these 32P-labeled probes. The integrity of the
RNA analyzed was con¢rmed by ethidium bromide staining, as shown in the bottom panel. Three independent experiments were per-
formed and gave similar results.
Fig. 5. Reversal by BMP-6 of the inhibitory action of
PTHrP(1^141) on the expression of type X collagen mRNA in
di¡erentiated ATDC5 cells. Cells were cultured in 6-multiwell
plastic plates as described in Section 2 for 21 days in the di¡er-
entiation medium and were then treated for an additional 48 h
with the submaximal dose of PTHrP(1^141) (1038 M), either
alone or in the presence of varying doses of BMP-6 (20, 50,
250 and 1000 ng/ml). Total RNA were prepared and subjected
to Northern analysis (20 Wg of total RNA per lane). The integ-
rity of the RNA analyzed was con¢rmed by ethidium bromide
staining, as shown in the bottom panel. Two independent ex-
periments were performed and gave similar results.
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tion in vitro and in vivo [5,8^10,22,23]. Shukunami et
al. reported that di¡erentiated ATDC5 cells express
PTHrP and PTH/PTHrP-R [14]. Thus, we examined
the e¡ect on the expression of type X collagen
mRNA by PTHrP(1^141). Treatment of di¡erenti-
ated ATDC5 cells with PTHrP(1^141), a full-length
form of the PTHrP molecule, resulted in downregu-
lation of the expression of type X collagen mRNA in
time- and dose-dependent manners (Fig. 4), indicat-
ing that PTHrP(1^141) inhibited the hypertrophic
conversion of ATDC5 cells.
We hypothesized that one of the possible mecha-
nisms underlying this inhibitory action of PTHrP(1^
141) on the hypertrophic conversion may be the
modulation of BMP-6 expression in ATDC5 cells.
As shown in Fig. 4, indeed, PTHrP(1^141) downre-
gulated the steady-state transcript level of BMP-6
gene in time- and dose-dependent manners.
3.5. Reversal by BMP-6 of the inhibitory action of
PTHrP(1^141) on the expression of type X
collagen mRNA in di¡erentiated ATDC5 cells
Our results that the expression of BMP-6 and
PTH/PTHrP-R mRNAs increased in parallel with
the progression of chondrogenic di¡erentiation and
that BMP-6 is stimulatory while PTHrP is inhibitory
to the hypertrophic conversion of di¡erentiated
ATDC5 cells, raise the possibility that BMP-6 and
PTHrP coordinately regulate the rate of the hyper-
trophic conversion of these cells. The di¡erentiated
ATDC5 cells were treated for 48 h with a submax-
imal dose of PTHrP(1^141) (1038 M), either alone or
in the presence of varying doses of BMP-6, and total
RNA was extracted (Fig. 5). Even in the presence of
PTHrP(1^141) (1038 M), BMP-6 increased the tran-
script level of type X collagen gene in a dose-depend-
ent manner. However, excess BMP-6 (1000 ng/ml)
did not override the inhibitory action of PTHrP(1^
141) (1038 M).
4. Discussion
Previous in vitro and in vivo studies provide evi-
dence that BMPs play important roles in chondro-
genic di¡erentiation [1^3,7,16,21]. The present study
has demonstrated that BMP-6 stimulated the hyper-
trophic conversion of ATDC5 cells as assessed by
Northern analyses of the gene expression of type X
collagen, a cartilage phenotypic marker gene speci¢-
cally expressed in hypertrophic chondrocytes. The
expression of BMP-6 mRNA in ATDC5 cells was
di¡erentiation stage-related; it increased in parallel
with the progression of chondrogenic di¡erentiation
and decreased as cells became hypertrophied. The
distinct expression pattern of BMP-6 mRNA in
ATDC5 cells is comparable with the localization of
BMP-6 gene transcripts in vivo [1,7,8], and suggests
that the action of BMP-6 is also di¡erentiation stage-
related in chondrogenic di¡erentiation. In this study,
we showed that exogenously administered BMP-6
upregulated the transcript level of type X collagen
gene in ATDC5 cells. This observation thus supports
the notion that BMP-6 expressed in chondrocytes
prior to the hypertrophic conversion stimulates the
cellular hypertrophy in vivo.
Solloway et al. recently reported that BMP-6 null
mice were not compromised in any of the skeletal
tissues in which it is expressed, with the exception
of the sternum which showed a delay in the hyper-
trophic conversion of proliferating chondrocytes and
the subsequent ossi¢cation [24]. This result suggests
that a null mutation of BMP-6 might be largely com-
pensated for or masked by related BMPs expressed
in bone rudiments, such as BMP-2 or BMP-4. This
hypothesis is consistent with our observations in this
study that BMP-4 also upregulated the expression of
type X collagen mRNA and that BMP-6 downregu-
lated the expression of BMP-4 mRNA in di¡erenti-
ated ATDC5 cells. In addition, BMP signals medi-
ated by BMP-6 and BMP-4 upregulated the
expression of BMP-6 mRNA. These results suggest
that although the regulatory mechanisms of BMP-4
mRNA expression as well as the protein levels of
BMP-6 and BMP-4 remain to be elucidated, the
gross amplitude of di¡erentiation signals increases
along with the transient expression of BMP-6 and
the constitutive expression of BMP-4 in ATDC5
cells.
Little is known regarding the receptor speci¢c to
BMP-6. Zou et al. showed that BMP receptor (BMP-
R) type IA was highly expressed in prehypertrophic
chondrocytes [21], raising the possibility that these
cells were the direct targets of BMP signals including
BMP-2, BMP-4, OP-1/BMP-7 and BMP-6. Since dif-
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ferentiated ATDC5 cells also express BMP-R type
IA mRNA (H. Akiyama et al., unpublished data),
it may be conceivable that the stimulatory e¡ect of
BMP-6 on the hypertrophic conversion is mediated
by BMP-R type IA in ATDC5 cells. Veri¢cation of
this hypothesis needs further study.
The rate of the hypertrophic conversion of prolif-
erating chondrocytes is required for the distinct reg-
ulatory mechanisms. We previously indicated that
acquisition of PTH/PTHrP responsiveness is closely
associated with chondrogenic di¡erentiation [14], and
in this study we found that PTHrP(1^141) markedly
downregulated the transcript level of type X collagen
gene in di¡erentiated ATDC5 cells. Moreover, BMP-
6 reversed the inhibitory action of the submaximal
dose of PTHrP(1^141) (1038 M) on the expression of
type X collagen in a dose-dependent manner in dif-
ferentiated ATDC5 cells. Furthermore, PTHrP(1^
141) downregulated the transcript level of BMP-6
gene in these cells. Taken together, these results pro-
vide evidence for the hypothesis that both BMP-6
and PTHrP signals coordinately regulate the rate of
the hypertrophic conversion.
In conclusion, we have shown that the transient
augmentation of BMP signals stimulates the hyper-
trophic conversion of ATDC5 cells and that one of
the possible mechanisms for the inhibitory action of
PTHrP on this cellular event is mediated by the
downregulation of BMP-6 expression.
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